CytoDyn Inc. Announces Adjournment of Annual Meeting of Shareholders to November 24, 2021 Due to…
VANCOUVER, Wash. - (BUSINESS WIRE) - Nov. October 2021--CytoDyn Inc.…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
CytoDyn
CytoDyn Inc. Announces Adjournment of Annual Meeting of Shareholders to November 24, 2021 Due to…
VANCOUVER, Wash. - (BUSINESS WIRE) - Nov. October 2021--CytoDyn Inc.…
CytoDyn Inc. Announces Adjournment of Annual Meeting of Shareholders to November 24, 2021 Due to…
Obtain on the spot notifications when there may be information about your shares. Request your one-week free trial of StreetInsider Premium right here.
Activist group did not submit their proxies
With out the representatives of…
CytoDyn Announces Delaware Court Has Denied Activist Group’s Motion to Prevent Annual Meeting from…
VANCOUVER, Wash .-- (BUSINESS WIRE) - CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Firm”), a late-stage biotechnology firm growing Leronlimab, a CCR5 antagonist with potential for a number of therapeutic indications, introduced…
CytoDyn Alerts Shareholders to Vote on Company’s Proxy Card Ahead of October 28th Annual Meeting
VANCOUVER, Wash .-- (BUSINESS WIRE) - CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Firm”), a late-stage biotechnology firm growing Leronlimab, a CCR5 antagonist with potential for a number of therapeutic indications, right now…
CytoDyn Alerts Shareholders to Vote on Company’s Proxy Card Ahead of October 28th Annual Meeting |…
VANCOUVER, Wash. - (BUSINESS WIRE) - Aug. October 2021--CytoDyn Inc.…
CytoDyn Alerts Shareholders to Vote on Company’s Proxy Card Ahead of October 28th Annual Meeting |…
VANCOUVER, Wash. - (BUSINESS WIRE) - Aug. October 2021--CytoDyn Inc.…
CytoDyn Files Form S-3 to Replace Expiring Shelf
VANCOUVER, Wash., March 03, 2021 (GLOBE NEWSWIRE) - CytoDyn Inc. (OTC.QB: CYDY), ("CytoDyn" or the "Firm"), a late-stage biotechnology firm creating Vyrologix ™ (Leronlimab-PRO 140), a CCR5 antagonist with potential for a number of…
CytoDyn Executes Exclusive Supply and Distribution Agreement with Chiral Pharma Corporation to…
CytoDyn is properly positioned within the Philippines with a Compassionate Particular Allow (CSP) to generate important earningsVANCOUVER, Wash., April 15, 2021 (GLOBE NEWSWIRE) - CytoDyn Inc. (OTC.QB: CYDY), ("CytoDyn" or the "Firm"), a…
CytoDyn Inc’s final mTNBC report indicates 980% increase in 12-month overall survival with…
The late-stage biotech firm additionally reported as much as a 660% improve in modified progression-free survival at 12 months in 30 metastatic triple-negative breast most cancers sufferers
CytoDyn Inc shared an replace on its beforehand…